Alimera Sciences, Inc. (NASDAQ: ALIM) (“Alimera”), a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals. Our lead product is ILUVIEN, now approved for marketing in the U...

Education

Pharmaceutical

Alimera Sciences

Alimera Sciences' headquarters in Alpharetta, GA, United States

Janine Ainslie Harris

Alexandre Benites

Anastasia Turano

Scott Campbell

Riz Siddiqi

Lillian Contreras

Kapil Kumar

Ben Flagler

Tom Sinnamon

Brittany Underhill

David Dyer

Deirdre O Reilly

David Gregory

Diane Reeves

Sergei Donskihh

Catherine Griffiths

Laura Cegala Sphr, Gphr

Steve Morris

Bill Garner

Ryan Armstrong

Lachelle Bucher

Sarah Maynard

Raneisha Sconion

Chris Fasanello

Toni Davis

Cheryl O'Keeffe

Balqis Rabadi

Emma Head

Laura Chambers

Beatriz Rumsey P. Torres

Joan Hester

Elaine Stevens

The Sales and Marketing team at Alimera Sciences is responsible for driving the commercialization of ILUVIEN and other ophthalmic pharmaceutical products. This team develops strategic marketing initiatives, manages sales operations, and builds relationships with healthcare professionals to maximize product adoption and market access. They also ensure the effective training and support of field staff, enabling them to deliver targeted messaging and education to prescribers in the retina care space.

Sales and Marketing

The Medical Affairs team at Alimera Sciences is responsible for bridging the gap between clinical research and clinical practice. They provide scientific and medical support for the company’s ophthalmic products, including ILUVIEN, through interactions with healthcare professionals, education initiatives, and data dissemination. The team also ensures compliance with regulations and collaborates with other departments to enhance the product's clinical value and improve patient outcomes.

Medical Affairs

The Leadership Team at Alimera Sciences is responsible for strategic decision-making and guiding the company's vision in ophthalmic pharmaceutical development. Comprising key executives such as the CEO, CMO, and Chief Retina Specialist, the team collaborates to oversee product commercialization, corporate communications, and operational efficiency, ensuring the successful delivery of innovative therapies like ILUVIEN to the market.

Leadership Team

The Clinical Operations and Research team at Alimera Sciences is responsible for overseeing the planning, implementation, and management of clinical trials for ophthalmic pharmaceuticals. They ensure regulatory compliance and data integrity while fostering collaboration among various stakeholders, including researchers and regulatory bodies. The team also focuses on analyzing clinical outcomes to support the development and commercialization of innovative treatments like ILUVIEN.

Clinical Operations and Research

Alimera Sciences

Org chart

Teams

Sales and Marketing

Medical Affairs

Leadership Team

Clinical Operations and Research

Offices

Alimera Sciences

Org chart

Teams

Sales and Marketing

Medical Affairs

Leadership Team

Clinical Operations and Research

Offices

Related companies